Search Results

The Future of Antiproliferative Therapies for Endovascular Interventions

Translational findings from the Ranger Paclitaxel-Coated Balloon data.

By Renu Virmani, MD, FACC

What Does Histology Say About Vessel Preparation in Femoropopliteal ISR?

Initial pilot study results on laser revascularization with adjunctive DCB use.

By Renu Virmani, MD, FACC, and Frank D. Kolodgie, PhD

What Does Histology Say About Vessel Preparation in Femoropopliteal ISR?

Initial pilot study results on laser revascularization with adjunctive DCB use.

By Renu Virmani, MD, FACC, and Frank D. Kolodgie, PhD

Vascular Healing After Arterial Access: A Histopathological Comparison of Standard Seldinger Versus a Novel Access Technology

By Rahul S. Patel, MD; Renu Virmani, MD; Frank D. Kolodgie, PhD; Debra Cogan, RN; and Zoltan Turi, MD

Safety of Drug-Coated Balloons: Insight from Preclinical Studies

Understanding the advantages and disadvantages that can result from different balloon technologies on the market.

By Kazuyuki Yahagi, MD; Frank D. Kolodgie, PhD; and Renu Virmani, MD

The Role of Preclinical Data in Drug-Coated Balloon Therapy

Drs. Virmani and Granada explain the importance of preclinical data, discuss key parameters for evaluation, and review the science behind clinical performance.

With Renu Virmani, MD, and Juan F. Granada, MD, FACC

The Role of Preclinical Data in Drug-Coated Balloon Therapy

Drs. Virmani and Granada explain the importance of preclinical data, discuss key parameters for evaluation, and review the science behind clinical performance.

With Renu Virmani, MD, and Juan F. Granada, MD, FACC

Perspectives on 2-Year Drug-Coated Balloon Data

A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.

With Marianne Brodmann, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Peter A. Schneider, MD; and Jos C. van den Berg, MD, PhD

Perspectives on 2-Year Drug-Coated Balloon Data

A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.

With Marianne Brodmann, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Peter A. Schneider, MD; and Jos C. van den Berg, MD, PhD

How Can DCB Design Impact Clinical Outcomes?

The technology and clinical outcomes of the Passeo-18 Lux DCB.

By Marianne Brodmann, MD, and Gunnar Tepe, MD